Company news
Rigel Pharmaceuticals, Inc. news in 2019
Rigel Pharmaceuticals, Inc.'s news releases, calls and decks from 2019, newest first.
Rigel Receives Positive CHMP Opinion for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe
November 14, 2019
Rigel Announces Upcoming Data Presentations at the 61st ASH Annual Meeting & Exposition
November 6, 2019
Rigel Announces Third Quarter 2019 Financial Results
November 4, 2019
Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results
October 28, 2019
Rigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst Call
October 22, 2019
Rigel Receives Positive Trend Vote from CHMP for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe
October 17, 2019
Rigel to Host Investor and Analyst Call on October 23, 2019
October 15, 2019
Rigel Secures Credit Facility for Up to $60 Million
October 1, 2019
Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia
September 22, 2019
Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update
August 5, 2019
Rigel Announces Conference Call and Webcast to Report Second Quarter 2019 Financial Results
July 29, 2019
Rigel to Present Two Posters Highlighting Fostamatinib at the 24 Congress of the European Hematology Association (EHA)
June 12, 2019